LABORATORY RESEARCH USE ONLY β This compound is NOT for human consumption, veterinary use, or therapeutic applications.
GLP-1 Receptor AgonistsMetabolic Research㪠RUO
Danuglipron
Molecular Data
Formula
C28H31F2N3O6S
Mol. Weight
561.00 Da
CAS Number
2301842-64-4
Purity
β₯98%
Appearance
White powder
Storage
Room temperature
Research Overview
Danuglipron is a small molecule, orally bioavailable GLP-1 receptor agonist developed as an alternative to injectable peptide GLP-1 agonists.
Mechanism of Action
Non-peptide GLP-1R agonist with oral bioavailability, activating receptor signaling through an allosteric binding mechanism.
Research Applications
Oral GLP-1 pharmacology, allosteric receptor activation studies, small molecule vs. peptide comparison, metabolic research.
Key Research Findings
Allosteric binding mechanism distinct from peptide orthosteric activation. Oral bioavailability enables new research paradigms.
MANDATORY DISCLAIMER: Danuglipron as referenced on this page is strictly for in-vitro laboratory research and forensic applications only. It is NOT for human consumption, veterinary use, diagnostic purposes, therapeutic applications, or any form of bodily introduction. Any reference to research outcomes pertains exclusively to controlled laboratory settings. Researchers must comply with all applicable local, state, and federal regulations.
